文献速递核素与放射性配体治疗骨显像与常规 SPECT

ISIT-QA:在体成像试验评估低计数定量SPECT方法在多种扫描仪-准直器配置下用于223Ra放射性药物治疗

ISIT-QA: In Silico Imaging Trial to Evaluate a Low-Count Quantitative SPECT Method Across Multiple Scanner-Collimator Configurations for 223Ra-Based Radiopharmaceutical Therapies.
PubMed 文献 · J Nucl Med · 2024-05-01

ISIT-QA在体成像试验模拟280例接受223Ra治疗的骨转移去势抵抗性前列腺癌虚拟患者,在9种SPECT扫描仪-准直器配置下评估投影域低计数定量SPECT(LC-QSPECT)方法。268例患者共2903个病灶的数据显示,LC-QSPECT重现性良好(组内相关系数>0.75)、准确度高(恢复系数集合均值1.00至1.02),且重现性、准确度和重测重复性均显著优于传统重建定量方法。

要点

  • LC-QSPECT在9种扫描仪-准直器配置下剂量估计重现性良好,组内相关系数>0.75。
  • LC-QSPECT准确度高,恢复系数集合均值为1.00至1.02。
  • 与传统重建定量相比,LC-QSPECT重现性、准确度和重测重复性均显著改善。

核心结论

  • LC-QSPECT在223Ra为基础的α放射性药物治疗中提供可重现、准确且可重复的剂量估计,这些发现为α放射性药物治疗剂量定量的多中心临床评估提供了有力推动。

研究设计与样本

  • ISIT-QA为在体成像试验,模拟280例接受223Ra为基础α放射性药物治疗的骨转移去势抵抗性前列腺癌虚拟患者,采用9种模拟SPECT扫描仪-准直器配置。
  • 最终使用268例接受223RaCl2治疗的虚拟前列腺癌患者共2903个病灶的数据评估LC-QSPECT。

主要发现

  • LC-QSPECT在9种扫描仪-准直器配置下剂量估计重现性良好,组内相关系数>0.75。
  • LC-QSPECT准确度高,恢复系数集合均值为1.00至1.02。
  • 与传统重建定量方法相比,LC-QSPECT在多种扫描仪-准直器配置间的重现性、准确度和重测重复性均显著改善。

关键数值与推荐

  • 主要目标为通过计算组内相关系数评估LC-QSPECT在多种扫描仪-准直器配置下剂量估计的重现性。
  • 同时比较两种定量方法在多种扫描仪-准直器配置下的重现性并评估准确度。
  • 在重测研究中评估方法的重复性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Personalized dose-based treatment planning requires accurate and reproducible noninvasive measurements to ensure safety and effectiveness. Dose estimation using SPECT is possible but challenging for alpha (α)-particle-emitting radiopharmaceutical therapy (α-RPT) because of complex γ-emission spectra, extremely low counts, and various image-degrading artifacts across a plethora of scanner-collimator configurations. Through the incorporation of physics-based considerations and skipping of the potentially lossy voxel-based reconstruction step, a recently developed projection-domain low-count quantitative SPECT (LC-QSPECT) method has the potential to provide reproducible, accurate, and precise activity concentration and dose measures across multiple scanners, as is typically the case in multicenter settings. To assess this potential, we conducted an in silico imaging trial to evaluate the LC-QSPECT method for a 223Ra-based α-RPT, with the trial recapitulating patient and imaging system variabilities. Methods: A virtual imaging trial titled In Silico Imaging Trial for Quantitation Accuracy (ISIT-QA) was designed with the objectives of evaluating the performance of the LC-QSPECT method across multiple scanner-collimator configurations and comparing performance with a conventional reconstruction-based quantification method. In this trial, we simulated 280 realistic virtual patients with bone-metastatic castration-resistant prostate cancer treated with 223Ra-based α-RPT. The trial was conducted with 9 simulated SPECT scanner-collimator configurations. The primary objective of this trial was to evaluate the reproducibility of dose estimates across multiple scanner-collimator configurations using LC-QSPECT by calculating the intraclass correlation coefficient. Additionally, we compared the reproducibility and evaluated the accuracy of both considered quantification methods across multiple scanner-collimator configurations. Finally, the repeatability of the methods was evaluated in a test-retest study. Results: In this trial, data from 268 223RaCl2 treated virtual prostate cancer patients, with a total of 2,903 lesions, were used to evaluate LC-QSPECT. LC-QSPECT provided dose estimates with good reproducibility across the 9 scanner-collimator configurations (intraclass correlation coefficient > 0.75) and high accuracy (ensemble average values of recovery coefficients ranged from 1.00 to 1.02). Compared with conventional reconstruction-based quantification, LC-QSPECT yielded significantly improved reproducibility across scanner-collimator configurations, accuracy, and test-retest repeatability ([Formula: see text] Conclusion: LC-QSPECT provides reproducible, accurate, and repeatable dose estimations in 223Ra-based α-RPT as evaluated in ISIT-QA. These findings provide a strong impetus for multicenter clinical evaluations of LC-QSPECT in dose quantification for α-RPTs.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Li Z, Benabdallah N, Luo J, et al. ISIT-QA: In Silico Imaging Trial to Evaluate a Low-Count Quantitative SPECT Method Across Multiple Scanner-Collimator Configurations for 223Ra-Based Radiopharmaceutical Therapies. J Nucl Med. 2024. PMID: 38575187. doi:10.2967/jnumed.123.266719

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。